financetom
Business
financetom
/
Business
/
Bharat Forge Q1 consolidated net profit at Rs 153 cr
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bharat Forge Q1 consolidated net profit at Rs 153 cr
Aug 12, 2021 8:27 AM

Auto components major Bharat Forge on Thursday posted a consolidated net profit of Rs 153 crore for the first quarter ended June 30. The company had reported a consolidated net loss of Rs 127 crore in the April-June quarter of the 2020-21 fiscal.

Revenue from operations rose to Rs 2,108 crore in the June quarter as against Rs 1,154 crore in the year-ago period, Bharat Forge said in a regulatory filing. The company during the quarter managed to deliver a solid across the board performance despite challenges posed by the COVID lockdown and subsequent impact on economic activity in India," Bharat Forge Chairman Managing Director BN Kalyani said.

Also Read:

Manappuram Finance falls 14% post-June quarter earnings; AUM at six-quarter low

During the quarter, the company completed the acquisition of Sanghvi Forgings at a cost of Rs 77.06 crore, he added. "This facility, although currently small in scale, will play a very meaningful role in expanding our product portfolio to address significant opportunities in the Indian Industrial space over the medium term," Kalyani noted.

He further said, "As part of our growth strategy, we continue to look at enhancing our presence in the Indian manufacturing ecosystem through organic and more importantly inorganic avenues in our core business and newer verticals."

Also Read: Buy, sell or hold? What should investors do we Cadila Healthcare post Q1 earnings

Looking ahead into the second quarter of the financial year 2021-22, the company expects the overall growth to continue supported by a recovery in the domestic MHCV market and sustained improvement in demand levels in the export market, Kalyani said. Potential impact on end demand because of supply issues pertaining to semiconductors and the sustained increase of input costs are factors to keep track of in the coming months, he added.

Bharat Forge shares on Thursday ended 6.58 percent up at Rs 835 apiece on the BSE.

First Published:Aug 12, 2021 5:27 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fannie Mae, Freddie Mac set to tighten real-estate lending rules, WSJ reports
Fannie Mae, Freddie Mac set to tighten real-estate lending rules, WSJ reports
Aug 5, 2024
(Reuters) - Mortgage financing firms Fannie Mae and Freddie Mac are set to impose stricter rules for commercial property lenders and brokers, following a budding regulatory crackdown on fraud in the multi-trillion dollar market, the Wall Street Journal reported on Monday. Lenders would have to independently verify financial information related to borrowers for apartment complexes and other multifamily properties, the...
BioAffinity Raises Nearly $1.8 Million From Offerings
BioAffinity Raises Nearly $1.8 Million From Offerings
Aug 5, 2024
01:50 PM EDT, 08/05/2024 (MT Newswires) -- BioAffinity Technologies ( BIAF ) said Monday it raised a total of under $1.8 million from a registered direct offering, concurrent private placement, and warrant inducement. The company said it issued 1,041,667 shares at $1.25 apiece to three existing accredited investors who exercised outstanding warrants for proceeds of $1.3 million. The investors also...
Jaguar Health to Detail Regulatory Strategy for Antidiarrheal Drug for Cancer Patients Next Week
Jaguar Health to Detail Regulatory Strategy for Antidiarrheal Drug for Cancer Patients Next Week
Aug 5, 2024
02:06 PM EDT, 08/05/2024 (MT Newswires) -- Jaguar Health ( JAGX ) Monday said it will explore ways to win additional regulatory approvals for its crofelemer antidiarrheal drug in patients with certain types of cancers, but failed to meet the primary endpoint across all tumor types. Crofelemer currently is approved by the US Food and Drug Administration to help control...
Church & Dwight Analysts Slash Their Forecasts After Q2 Results
Church & Dwight Analysts Slash Their Forecasts After Q2 Results
Aug 5, 2024
Church & Dwight Co., Inc ( CHD ). reported upbeat second-quarter adjusted EPS results on Friday. Church & Dwight ( CHD ) reported quarterly earnings of 93 cents per share which beat the analyst consensus estimate of 84 cents per share. The company reported quarterly sales of $1.511 billion which met the analyst consensus estimate, according to data from Benzinga...
Copyright 2023-2026 - www.financetom.com All Rights Reserved